Jones Financial Companies
CPRX icon

Jones Financial Companies’s Catalyst Pharmaceutical CPRX Stock Holding History

Jones Financial Companies’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$142K Buy
6,076
+482
+9% +$11.5K ﹤0.01% 2527
2025
Q4 		$131K Buy
5,594
+1,533
+38% +$34.1K ﹤0.01% 2113
2025
Q3 		$79.3K Buy
4,061
+498
+14% +$10.2K ﹤0.01% 2173
2025
Q2 		$77.6K Buy
3,563
+890
+33% +$21K ﹤0.01% 2043
2025
Q1 		$66K Buy
2,673
+1,718
+180% +$38.7K ﹤0.01% 1948
2024
Q4 		$19.9K Buy
955
+255
+36% +$5.48K ﹤0.01% 2265
2024
Q3 		$13.7K Buy
700
+200
+40% +$3.71K ﹤0.01% 2091
2024
Q2 		$7.75K Buy
+500
New +$7.78K ﹤0.01% 1835

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jones Financial Companies's CPRX Position: Q1 2026 in Review

Jones Financial Companies increased its Catalyst Pharmaceutical (CPRX) stake by 8.6% in Q1 2026, buying an estimated $11.5K and bringing the position to 6,076 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Jones Financial Companies first reported a position in CPRX in Q2 2024 and has held it in 8 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Jones Financial Companies held 6,076 shares of Catalyst Pharmaceutical worth $142K as of Q1 2026.
  • Jones Financial Companies bought 482 Catalyst Pharmaceutical shares in Q1 2026, an estimated $11.5K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2527 holding.
  • Jones Financial Companies first reported a position in Catalyst Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.